MAPT and Alzheimer disease: AD brain pathology is associated with a lower concentration of Aβ42 and a lower ratio of Aβ42:Aβ40 in the CSF, probably due to sequestration of Aβ42 into amyloid plaques3, but higher concentrations of CSF total tau (t-tau) and p-tau181 (refs. 4,5).